Komori
Pharmarise Holdings (2796) · InitiativeAdvanced

Subsidiary Reorganization and More Efficient Store Operations

First written in FY2016. 18 of 26 entries say "Advanced", first in FY2017-Q1. Latest entry: FY2026.

26entries
11years
3from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2017-Q1 – FY2018-Q3AdvancedFY2019-Q3 – FY2021-Q1AdvancedFY2023-Q2 – FY20242016: 22017: 220172018: 320182019: 320192020: 320202021: 220212022: 220222023: 220232024: 120242025: 120252026: 52026
Same theme, other companies
Centralization and greater efficiency in group management through the merger and integration of subsidiariesA theme 205 companies write about · 1 as a headwind · 217 as a tailwind

25 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 185 companies compared. The sentences above are computed from all 185.Comparing 200 of the theme's 224 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「While expanding the scale of the dispensing pharmacy business through the M&A pursued through the previous consolidated fiscal year, we rapidly advanced integration activities, thereby achieving higher revenue and improved profitability.」

    The company stated that rapidly advancing post-M&A integration activities led to higher revenue and improved profitability.
  2. FY2026-H1AdvancedAnnual report

    「As a result of proactively pursuing M&A during the previous fiscal year as a measure to strengthen earnings in the core dispensing pharmacy business, the Group increased revenue. Its rapid post-acquisition integration efforts have also contributed steadily to profit growth.」

    The focus of subsidiary reorganization and operating efficiency has progressed concretely toward accelerating post-M&A integration activities, improving head-office operations and increasing profit.
  3. FY2025ReframedAnnual report

    「The period covered by the medium-term management plan is positioned as a foundation-building period for achieving further growth centered on the dispensing pharmacy business, by completing the post-M&A integration process for newly added Group companies and stores as quickly as possible and raising profit margins and operating efficiency.」

    The focus of subsidiary reorganization and operating efficiency has been reframed from the previous emphasis on organizational restructuring to completing post-M&A integration for companies and stores and improving profit margins and operating efficiency.
  4. FY2024AdvancedAnnual report

    「The company is working to reduce costs, including through the consolidation of administrative functions and cash management functions at head office and the introduction of systems for these functions across each subsidiary, as well as through lower interest costs.」

    As part of the review of operating processes and the Group's organizational structure, the company is concretely advancing the consolidation and systemization of administrative and cash management functions at head office.
  5. FY2023AdvancedAnnual report

    「March 2023: An absorption-type company split in which ファーマライズ株式会社 was the split company and 北海道ファーマライズ株式会社 was the successor company.」

    The company established 北海道ファーマライズ株式会社 and carried out an absorption-type company split from ファーマライズ株式会社 in March 2023, giving concrete form to the reorganization of the Group's structure and store operations.
  6. FY2023-Q2AdvancedAnnual report

    「In addition, net income attributable to owners of the parent declined year on year, mainly because the company terminated a fixed-term lease agreement in order to operate its head-office-related offices more efficiently and recorded the resulting amount as an extraordinary loss.」

    The company terminated a fixed-term lease agreement to improve the efficiency of its head-office-related offices.
  7. FY2022RestatedAnnual report

    「We will review our operating processes and the Group's organizational structure. Specifically, we will conduct an inventory of operating processes not only for stores but also for head-office functions, undertake a fundamental review, and reduce costs by automating and improving the efficiency of the relevant tasks.」

    The company is continuing to improve the earnings structure by reviewing store and head-office operations, automating and improving efficiency, and transforming the Group's organizational structure.
  8. FY2022-Q2ReframedAnnual report

    「③ We will promote improvements to the earnings structure by further strengthening the management base.」

    The improvements previously described as resulting from a review of operating methods and the Group's organizational structure have been reframed in the new medium-term management plan as improving the earnings structure through further strengthening of the management base.
  9. FY2021RestatedAnnual report

    「We will review our operating processes and the Group's organizational structure. Specifically, we will conduct an inventory of operating processes not only for stores but also for head-office functions, undertake a fundamental review, and reduce costs by automating and improving the efficiency of the relevant tasks.」

    The company is continuing its policy of reducing costs by reviewing store and head-office operations, automating and improving efficiency, and transforming the Group's organizational structure.
  10. FY2021-Q2RestatedAnnual report

    「This was due to progress in improving profitability through the closure of unprofitable stores and expense reductions, despite the impact of COVID-19.」

    The company is continuing to improve store operating efficiency and profitability by closing unprofitable stores and reducing expenses.
  11. FY2021-Q1AdvancedAnnual report

    「This was due to improved profitability resulting from the closure of unprofitable stores and expense reductions, despite the impact of COVID-19.」

    The company stated that it closed unprofitable stores and reduced expenses, leading to improved profitability in the merchandise business.
  12. FY2020AdvancedAnnual report

    「During the consolidated fiscal year, to consolidate management resources, improve management efficiency and further strengthen the business base, 関西ファーマライズ株式会社, 株式会社エム・シー and 薬ヒグチ&ファーマライズ株式会社, 3 companies in total, were absorbed and merged effective 1 June 2019, with ファーマライズ株式会社 as the surviving company. In addition, 新世薬品株式会社 and 株式会社ドゥリーム, 2 companies in total, were absorbed and merged effective 1 September 2019, with ファーマライズ株式会社 as the surviving company.」

    In June and September, 5 companies in total were absorbed and merged into ファーマライズ株式会社, and the organizational and cost structures were reviewed.
  13. FY2020-Q2AdvancedAnnual report

    「Effective 1 September 2019, 新世薬品株式会社 and 株式会社ドゥリーム, 2 companies in total, were absorbed and merged, with ファーマライズ株式会社 as the surviving company. During the six-month consolidated period, to consolidate management resources, improve management efficiency and further strengthen the business base, 関西ファーマライズ株式会社, 株式会社エム・シー and 薬ヒグチ&ファーマライズ株式会社, 3 companies in total, were absorbed and merged effective 1 June 2019, with ファーマライズ株式会社 as the surviving company.」

    Effective 1 June and 1 September 2019, 5 companies in total were absorbed and merged into ファーマライズ株式会社, advancing the review of the organizational and cost structures.
  14. FY2020-Q1AdvancedAnnual report

    「During the three-month period, to consolidate management resources, improve management efficiency and further strengthen the business base, 関西ファーマライズ株式会社, 株式会社エム・シー and 薬ヒグチ&ファーマライズ株式会社, 3 companies in total, were absorbed and merged effective 1 June 2019, with ファーマライズ株式会社 as the surviving company.」

    Effective 1 June 2019, 3 companies were absorbed and merged into ファーマライズ株式会社, advancing the consolidation of management resources and the review of the organizational and cost structures. The company also disclosed that 新世薬品株式会社 and 株式会社ドゥリーム were absorbed and merged effective 1 September 2019.
  15. FY2019-Q3AdvancedAnnual report

    「An absorption-type merger in which ファーマライズ株式会社 is the surviving company and 東海ファーマライズ株式会社, 北海道ファーマライズ株式会社, 株式会社エシックス and 株式会社フォーユー are the absorbed companies.」

    The company signed a merger agreement to integrate 5 consolidated subsidiaries into ファーマライズ株式会社, with 1 March 2019 as the effective date. It stated that the integration of the 5 subsidiaries' management resources would improve management efficiency and enhance corporate value.
  16. FY2019-Q2ReframedAnnual report

    「③ We are promoting improvements to the earnings structure by reviewing operating methods and the Group's organizational structure.」

    The previous focus on subsidiary reorganization and store operating efficiency has been reframed in the new medium-term management plan as improving the earnings structure through a review of operating methods and the Group's organizational structure.
  17. FY2018RestatedAnnual report

    「We will accelerate steady growth through the continued opening of stores and pursuit of M&A, subsidiary reorganization, and expansion of non-dispensing businesses.」

    The company plans to further accelerate measures to improve management efficiency, including subsidiary reorganization.
  18. FY2018-Q3AdvancedAnnual report

    「Effective 1 December 2017, 株式会社双葉, which operated 8 stores in Kyoto, was absorbed by 株式会社テラ・ヘルスプロモーション, the surviving company, and 有限会社イノセ商事, which operated 1 store in Saitama, was absorbed by ファーマライズ株式会社, the surviving company. On the same date, 1 store operated in Osaka by 新世薬品株式会社 was transferred to 株式会社テラ・ヘルスプロモーション through an absorption-type company split.」

    The company absorbed and merged 双葉 and 有限会社イノセ商事 and transferred 1 store operated by 新世薬品 through an absorption-type company split, further advancing subsidiary reorganization and the consolidation of store operations.
  19. FY2018-Q2AdvancedAnnual report

    「During the six-month consolidated period, to consolidate management resources, improve management efficiency and further strengthen the business base, 株式会社鬼怒川調剤センター, which operated 1 store in Tochigi Prefecture, was absorbed and merged effective 1 June 2017, with ファーマライズ株式会社 as the surviving company.」

    Effective 1 June 2017, 株式会社鬼怒川調剤センター was absorbed and merged, advancing subsidiary reorganization and the consolidation of management resources, including its 1 store.
  20. FY2017AdvancedAnnual report

    「Effective 1 March 2017, 1 store operated by ファーマライズプラス株式会社 in Tokyo and 1 store operated in Chiba were transferred through a business transfer to 薬ヒグチ&ファーマライズ株式会社. On the same date, ファーマライズプラス株式会社, which operated 8 stores in Tokyo as of the end of February 2017 excluding the 2 stores above, was absorbed and merged, with ファーマライズ株式会社 as the surviving company. On the same date, 株式会社川口薬局, which operated 3 stores in Hokkaido as of the end of February 2017, was also absorbed and merged, with 北海道ファーマライズ株式会社 as the surviving company.」

    The company transferred stores operated by ファーマライズプラス株式会社 and absorbed and merged that company, and also absorbed and merged 株式会社川口薬局, further advancing subsidiary reorganization and the consolidation of store operations.
  21. FY2017-Q2AdvancedAnnual report

    「Effective 1 September 2016, 12 stores operated by ファーマライズ株式会社 in Aichi Prefecture, 3 stores in Shiga Prefecture and 2 stores in Gifu Prefecture were transferred through an absorption-type company split to 株式会社みなみ薬局 (now 東海ファーマライズ株式会社). Subsequently, effective 1 October 2016, 株式会社みなみ薬局 changed its corporate name to 東海ファーマライズ株式会社.」

    Following the transfer of stores effective 1 June, a total of 17 stores were transferred through an absorption-type company split effective 1 September, and effective 1 October, 株式会社みなみ薬局 changed its corporate name to 東海ファーマライズ株式会社. The company is making concrete progress on subsidiary reorganization and the consolidation of management resources.
  22. FY2017-Q1AdvancedAnnual report

    「During the first quarter of the consolidated fiscal year, to consolidate management resources, improve management efficiency and further strengthen the business base, 11 stores operated by ファーマライズ株式会社 in Shizuoka Prefecture, 1 store operated in Yamanashi Prefecture and 1 store operated in Aichi Prefecture were transferred through an absorption-type company split to 株式会社みなみ薬局 effective 1 June 2016. On the same date, 3 stores operated by 株式会社みなみ薬局 in Fukushima Prefecture and 1 store operated in Yamagata Prefecture were transferred through an absorption-type company split to ファーマライズ株式会社.」

    Effective 1 June 2016, a total of 16 stores were transferred between the two companies through absorption-type company splits, advancing the consolidation of management resources.
  23. FY2016First statedAnnual report

    「As part of measures to improve management efficiency, we have continued to reorganize subsidiaries to improve store operating efficiency and close unprofitable and duplicate stores.」

    The group is consolidating management resources through mergers of subsidiaries, transfers of stores and the disposal of unprofitable and duplicate locations.
Moved together

"Expanding Scale and Store Network through M&A and New Store Openings" moved the same way as this thread, in the same document, in 15 of its 26 moves.

1587766★123456
  1. ★This thread
  2. 1Expanding Scale and Store Network through M&A and New Store Openings15×
  3. 2Unprofitable Stores and the Risk of Impairment of Fixed Assets8×
  4. 3Strengthening Community Healthcare through Home Healthcare and Institutional Dispensing7×
  5. 4Reliance on Borrowings and Interest-Rate and Financial-Covenant Risks7×
  6. 5Profit improvement in the dispensing pharmacy business driven by an increase in prescriptions and fees for dispensing services6×
  7. 6Establishing a Sustainability Committee and Strengthening ESG Initiatives6×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Pharmarise Holdings's next results are scheduled for 2026-09-17. Read the earnings preview It last moved in the General Meetings of Shareholders of 2026-07-28: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Subsidiary Reorganization and More Efficient Store Operations | Pharmarise Holdings Corporation (2796) | Komori